Success Metrics

Completion Rate
0%(0/4)
Active Trials
0(0%)
Terminated
4(57%)

Phase Distribution

Ph phase_2
3
43%
Ph phase_1
4
57%

Phase Distribution

4

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
3(42.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 7 finished

Non-Completion Rate

100.0%

7 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Terminated(7)

Detailed Status

Terminated4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
0.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (57.1%)
Phase 23 (42.9%)

Trials by Status

withdrawn343%
terminated457%

Recent Activity

0 active trials
Showing 5 of 7
terminatedphase_1

A Study of ALXN1830 in Healthy Adult Participants

NCT04730804
terminatedphase_1

A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants

NCT05254613
withdrawnphase_2

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

NCT04982289
withdrawnphase_2

Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia

NCT04956276
withdrawnphase_2

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

NCT04256148
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04730804Phase 1

A Study of ALXN1830 in Healthy Adult Participants

Terminated
NCT05254613Phase 1

A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants

Terminated
NCT04982289Phase 2

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

Withdrawn
NCT04956276Phase 2

Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia

Withdrawn
NCT04256148Phase 2

ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia

Withdrawn
NCT03075878Phase 1

A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Terminated
NCT03075904Phase 1

A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7